What is an FDA warning letter, and how should your company respond once it has received one? In today’s episode, Darshan Kulkarni talks with former FDA inspector Patrick Stone about the auditing process in compounding pharmacies, and how companies should address warning letters issued by the FDA. Plus, we’ll discuss the repercussions of ignoring FDA Form 483 findings.
Join host @Darshankulkarni on this upcoming episode of @Darshantalks as he welcomes guest @SandraLeal to talk about Being a National...
A brief discussion on the history of antibiotics from history maven Douglas Bucklin PhD.
We had a conversation with Vivian Juter Frankel, CEO of #PharmaSalon, about the importance of practical #compoundingpharmacy education. We...
